Closed

Supply of Cryopreservation-Grade Dimethyl Sulfoxide (DMSO) Products

NHS Blood and Transplant

Value
£1,200,000
Published
10 Aug 2026
Deadline
11 Sept 2026
Procedure
Not stated
Category
33696500 — Laboratory reagents; 33600000 — Pharmaceutical products; 33140000 — Medical consumables
Location
UK, United Kingdom
Notice reference
075629-2026

Requirements summary

NHS Blood and Transplant (NHSBT) is running a preliminary market engagement ahead of a possible future procurement for sterile, pyrogen-free Dimethyl Sulfoxide (DMSO) used in cryopreserving stem cell and immunotherapy products. The indicative value is GBP 1.2m gross (GBP 1.0m net), with a planned contract period from 1 February 2027 to 1 February 2031 and a possible extension to 2035. Products would be delivered across NHSBT Cellular and Molecular Therapies laboratories in the UK.

Key requirements

  • Sterile, pyrogen-free liquid DMSO with minimum 99.9% purity, ready for use
  • Compliance with European and/or United States Pharmacopoeia standards, and UKCA or CE marking where applicable
  • Lot 1: vials or bottles; Lot 2: alternative containers such as bags or syringes suitable for sterile docking
  • Certificate of Analysis/Compliance with each batch, clear batch and expiry labelling, and at least six months' shelf life remaining on delivery
  • Contingency stock equal to at least three months' NHSBT demand, with guaranteed supply continuity and replacement of unsatisfactory stock within 24 hours
  • Business continuity, product recall, complaint handling, adverse event management, and agreement to quality audits
  • Delivery to NHSBT CMT laboratories in Barnsley, Birmingham, Filton, Oxford and Southampton
  • Expressions of interest due by 17:00 BST on 21 August 2026; market engagement runs 24 August to 4 September 2026

Similar open notices

Supply of Cryopreservation-Grade Dimethyl Sulfoxide (DM… | ProposAI